In a preclinical ovarian cancer model examining the role of IL-6 in cancer-related cachexia, they discovered severe weight loss and progressive muscle wasting due to altered metabolism and elevated levels of IL-6, p-STAT3, and reduced p-Akt levels [84]. This evidence concerns the gene IL6 and cancer.